What does the evidence say about Iron Sleep Quality Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Iron Sleep Quality Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - However, the evidence base for TCM pharmacologic interventions in hemodialysis-related RLS remains unclear. [Zhang J (2026); evidence level 1] - Pharmacologic therapy significantly improved IRLS scores (MD -7.84), sleep quality (SMD -0.82), and quality of life (SMD 0.48). [Zhang J (2026); evidence level 1] - A heatmap further revealed that dopaminergic agents were associated with the highest frequency of adverse events, particularly nausea, hypotension, and augmentation. [Zhang J (2026); evidence level 1] - Background Restless Legs Syndrome (RLS) is highly prevalent among adults receiving maintenance hemodialysis and significantly impairs sleep, psychological well-being, and quality of life. [Zhang J (2026); evidence level 1] - This review synthesizes evidence on the prevalence, outcomes, and pathophysiology of RLS in various neurological disorders, including Parkinson's disease, multiple sclerosis, migraine, dementia, stroke, epilepsy, and peripheral neuropathy. [Ghattas K (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.